Twitter | Pretraživanje | |
Pretraživanje Osvježi
肺高血圧_千葉 bot 8 h
Japanese Pulmonary Hypertension Society HP →
Reply Retweet Označi sa "sviđa mi se"
Royal Papworth Hospital Library 12 h
new publication: Familial pulmonary arterial hypertension by KDR heterozygous loss of function. .
Reply Retweet Označi sa "sviđa mi se"
Owlstone Medical 16 h
Interested in ? Take a look at how VOC can help to distinguish patients from controls. Our products offer a potential route for which could improve survival rates & clinical outcomes.
Reply Retweet Označi sa "sviđa mi se"
Definitely not Bill. Probably his lawyer. 5. velj
Odgovor korisniku/ci @morethanmySLE @charles_gaba
Daughter with . meds are super expensive and it’s a rare genetic disease. is a huge concern. Also continued access to meds under whatever plan is proposed by Dems.
Reply Retweet Označi sa "sviđa mi se"
Rebecca Vanderpool, PhD 4. velj
An excellent new paper utilizing ML and imaging in
Reply Retweet Označi sa "sviđa mi se"
Laurent Bertoletti 4. velj
Odgovor korisniku/ci @SarahMedrek @SouadBzh i 3 ostali
Never heard about this! Interesting case, isn't it and others friends?
Reply Retweet Označi sa "sviđa mi se"
PhaseBio 4. velj
announces case study highlighting hemodynamic data that supports the potential of PB1046, a once-weekly VIP analogue for adults with pulmonary arterial hypertension and was presented at the 14th PVRI World Congress.
Reply Retweet Označi sa "sviđa mi se"
PHA EUROPE 4. velj
Dear All, SAVE THE DATE: Online Webinar - Growing up with PH and the role of parents and family - Tuesday 25 February, 08:00 PST, 16:00 GMT, 17:00 CET <3
Reply Retweet Označi sa "sviđa mi se"
European Society of Cardiology Journals 4. velj
can help w/ automatic extraction of arterial hypertension features from cardiac w/ high diagnostic accuracy as Swift et al. showed in their recent work published in
Reply Retweet Označi sa "sviđa mi se"
Ramcés Falfán-Valencia 3. velj
as a novel negative regulator/transcriptional repressor ID1 & an upstream propagator of a signal converging on and CD47. Insight into the cellular & molecular effects of a functional genetic variant linked to altered outcomes .
Reply Retweet Označi sa "sviđa mi se"
ndd Medical 3. velj
February is . In our next , Benefits of in Cardiology, we'll discuss the clinical significance of DLCO as it relates to & . When? 2/20 @ 2:30PM EST Register today!
Reply Retweet Označi sa "sviđa mi se"
PH Association 3. velj
Ke Yuan, Ph.D., received the 2019 PHA Aldrighetti Research Award for Young Investigators for her proposal regarding vascular remodeling in pulmonary arterial hypertension (). Read more about her proposed research here:
Reply Retweet Označi sa "sviđa mi se"
AJP - Lung 2. velj
Editorial Board member Dr. Vinicio de Jesus Perez (right; ) with poster presenters at in Lima, Peru. Read some of Dr. de Jesus Perez's work on drug-induced in at &
Reply Retweet Označi sa "sviđa mi se"
HSP90 Resource Guide 31. sij
Lessons from Cancer: subcellular drug targeting of mitochondrial in pulmonary arterial hypertension
Reply Retweet Označi sa "sviđa mi se"
Luke Howard 30. sij
Odgovor korisniku/ci @HelpMyBreathing
So much good work from the Robbins' lab showing how iron status can modulate acute responses to hypoxia, however we're still a way off understanding how to manipulate the iron axis for the better in
Reply Retweet Označi sa "sviđa mi se"
Orla Owen 30. sij
Good. Ness. Me. I’ve cut about 60,000 words from that I like - characters from the town that feel so real but they were confusing the main story. Does anyone else get carried away like that? Upside is when Netflix come calling, I’m sorted for content... 🎬📚
Reply Retweet Označi sa "sviđa mi se"
♫ ♪ Kirsten 🌙☀️ 30. sij
Project losing weight is working pretty well. At least for the moment. Only around 6 more kilos to go for a BMI <30.
Reply Retweet Označi sa "sviđa mi se"
S Faiz 30. sij
Odgovor korisniku/ci @PGeorgeMD
Looks amazing! Would ❤️ to see some live tweeting of these talks!
Reply Retweet Označi sa "sviđa mi se"
The NPWP 29. sij
Gotta love Tuesday nights! On Wednesdays, we practice at home... @ North Penn High School
Reply Retweet Označi sa "sviđa mi se"
Healio Pulmonology 29. sij
Sotatercept met the primary and key secondary endpoints of the PULSAR phase 2 trial in patients with , according to the press release
Reply Retweet Označi sa "sviđa mi se"